Top Predictions for IT Organizations and Users for 2014 and Beyond

By 2016, 3D printing of tissues and organs (bioprinting) will cause a global debate about regulating the technology or banning it for both human and nonhuman use. Near-term flag: The U.S. Food and Drug Administration or comparable agency in a developed nation that is charged with evaluating all medical proposals will introduce guidelines that prohibit the bioprinting of life-saving 3D printed organs and tissues without its prior approval by end of 2015.

Bioprinting is the medical application of 3D printers to produce living tissue and organs. The day when 3D bioprinted human organs are readily available is drawing closer. The emergence of 3D bioprinting facilities with the ability to print human organs can leave people wondering what the effect of it will be on society. Beyond these questions, however, there is the reality of what 3D bioprinting means in helping people who need organs that are otherwise not readily available.